We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Invitrogen Launches New RNAi Vectors
Product News

Invitrogen Launches New RNAi Vectors

Invitrogen Launches New RNAi Vectors
Product News

Invitrogen Launches New RNAi Vectors


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Invitrogen Launches New RNAi Vectors"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Invitrogen Corporation announced the launch of two new vectors for RNAi research. The BLOCK-iT™ HiPerform™ Lentiviral PolII miR RNAi Expression System with Emerald Green Fluorescent Protein (EmGFP) offers the expected ability to deliver to nondividing, primary, and hard-to-transfect cells with lentiviral technology coupled to multi-site technology for promoter flexibility making it ideal for difficult applications including in vivo RNAi. The new vector contains an mRNA stabilizing sequence (WPRE) and a nuclear import sequence (cPPT) which generate up to 5-fold higher virus titers and emGFP expression than previous versions. The BLOCK-iT™ Inducible PolII miR RNAi Expression System uses a tetracycline-inducible promoter that allows researchers to control miR RNAi expression so that even genes that are essential to the function of a cell may be knocked down.

Advertisement